CB
MDT icon

Cooke & Bieler’s Medtronic MDT Stock Holding History

Cooke & Bieler’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.5M Sell
799,208
-12,822
-2% -$1.03M 0.72% 58
2026
Q1 		$70.4M Sell
812,030
-130,094
-14% -$12.5M 0.8% 53
2025
Q4 		$90.5M Sell
942,124
-6,321
-0.7% -$614K 0.94% 52
2025
Q3 		$90.3M Sell
948,445
-108,273
-10% -$9.95M 0.93% 47
2025
Q2 		$92.1M Sell
1,056,718
-29,016
-3% -$2.46M 0.92% 47
2025
Q1 		$97.6M Sell
1,085,734
-11,648
-1% -$1.04M 0.98% 43
2024
Q4 		$87.7M Sell
1,097,382
-20,143
-2% -$1.74M 0.84% 50
2024
Q3 		$101M Sell
1,117,525
-19,517
-2% -$1.64M 0.91% 45
2024
Q2 		$89.5M Sell
1,137,042
-595,268
-34% -$48.8M 0.86% 50
2024
Q1 		$151M Sell
1,732,310
-156,662
-8% -$13.4M 1.4% 29
2023
Q4 		$156M Sell
1,888,972
-60,357
-3% -$4.6M 1.37% 26
2023
Q3 		$153M Buy
1,949,329
+10,902
+0.6% +$913K 1.49% 20
2023
Q2 		$171M Sell
1,938,427
-13,638
-0.7% -$1.17M 1.59% 19
2023
Q1 		$157M Sell
1,952,065
-58,831
-3% -$4.79M 1.53% 17
2022
Q4 		$156M Buy
2,010,896
+149,516
+8% +$12.1M 1.53% 21
2022
Q3 		$150M Buy
1,861,380
+277,258
+18% +$24.9M 1.61% 15
2022
Q2 		$142M Buy
1,584,122
+500,384
+46% +$50.7M 1.37% 28
2022
Q1 		$120M Buy
1,083,738
+58,965
+6% +$6.23M 1.06% 44
2021
Q4 		$106M Buy
1,024,773
+127,238
+14% +$14.7M 0.91% 50
2021
Q3 		$113M Buy
897,535
+169,838
+23% +$22M 1.02% 39
2021
Q2 		$90.3M Sell
727,697
-23,079
-3% -$2.9M 0.83% 51
2021
Q1 		$88.7M Sell
750,776
-18,545
-2% -$2.17M 0.86% 48
2020
Q4 		$90.1M Buy
769,321
+14,369
+2% +$1.58M 0.99% 46
2020
Q3 		$78.5M Buy
754,952
+38,350
+5% +$3.85M 1.05% 43
2020
Q2 		$65.7M Sell
716,602
-3,270
-0.5% -$314K 0.9% 55
2020
Q1 		$64.9M Buy
719,872
+87,176
+14% +$9.27M 1.05% 50
2019
Q4 		$71.8M Sell
632,696
-217,632
-26% -$23.9M 0.77% 61
2019
Q3 		$92.4M Sell
850,328
-118,625
-12% -$12.4M 1.57% 26
2019
Q2 		$94.4M Buy
+968,953
New +$88.5M 1.65% 26

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cooke & Bieler's MDT Position: Q2 2026 in Review

Cooke & Bieler reduced its Medtronic (MDT) stake by 1.6% in Q2 2026, selling an estimated $1.03M and leaving 799,208 shares worth $62.5M. The position accounts for 0.72% of the portfolio, ranked #58.

Cooke & Bieler first reported a position in MDT in Q2 2019 and has held it in 29 quarters since. The position peaked at $171M in Q2 2023. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cooke & Bieler held 799,208 shares of Medtronic worth $62.5M as of Q2 2026.
  • Cooke & Bieler sold 12,822 Medtronic shares in Q2 2026, an estimated $1.03M.
  • Medtronic made up 0.72% of Cooke & Bieler's portfolio in Q2 2026, its #58 holding.
  • Cooke & Bieler first reported a position in Medtronic in Q2 2019 and has held it in 29 quarters since.
  • Cooke & Bieler's Medtronic position peaked at $171M in Q2 2023.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cooke & Bieler's 13F filing for Q2 2026, filed 30 Jul 2026.